Early-Stage Chronic Kidney Disease and Related Health Care Spending

被引:3
|
作者
Sakoi, Naomi [2 ,3 ]
Mori, Yuichiro [3 ]
Tsugawa, Yusuke [4 ,5 ]
Tanaka, Junko [2 ]
Fukuma, Shingo [1 ,3 ]
机构
[1] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Shogoin Kawaharamachi 54,Sakyo, Kyoto 6068507, Japan
[2] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan
[3] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan
[4] David Geffen Sch Med UCLA, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA
[5] UCLA Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA
关键词
CARDIOVASCULAR-DISEASE; CKD; AWARENESS; COST; EXPENDITURES; POPULATION; OUTCOMES; TRENDS; NEED;
D O I
10.1001/jamanetworkopen.2023.51518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance The global burden of chronic kidney disease (CKD) is substantial and potentially leads to higher health care resource use.Objective To examine the association between early-stage CKD and health care spending and its changes over time in the general population.Design, Setting, and Participants Cohort study using nationwide health checkup and medical claims data in Japan. Participants included individuals aged 30 to 70 years with estimated glomerular filtration rates (eGFR) of 30 mL/min/1.73 m(2) or greater at the baseline screening in 2014. Data analyses were conducted from April 2021 to October 2023.Exposure The CKD stages at baseline, defined by the eGFR and proteinuria, were as follows: eGFR of 60 mL/min/1.73 m(2) or greater without proteinuria, eGFR of 60 mL/min/1.73 m(2) or greater with proteinuria, eGFR of 30 to 59 mL/min/1.73 m(2) without proteinuria, and eGFR of 30 to 59 mL/min/1.73 m(2) with proteinuria.Main Outcome and Measures The primary outcome was excess health care spending, defined as the absolute difference in health care spending according to the baseline CKD stages (reference group: eGFR >= 60 mL/min/1.73 m(2) without proteinuria) in the baseline year (2014) and in the following 5 years (2015 to 2019).Results Of the 79 988 participants who underwent a health checkup (mean [SD] age, 47.0 [9.4] years; 22 027 [27.5%] female), 2899 (3.6%) had an eGFR of 60 mL/min/1.73 m(2) or greater with proteinuria, 1116 (1.4%) had an eGFR of 30 to 59 mL/min/1.73 m(2) without proteinuria, and 253 (0.3%) had an eGFR of 30 to 59 mL/min/1.73 m(2) with proteinuria. At baseline, the presence of proteinuria and an eGFR less than 60 mL/min/1.73 m(2) were associated with greater excess health care spending (adjusted difference, $178; 99% CI, $6-$350 for proteinuria; $608; 99% CI, $233-$983 for an eGFR of 30-59 mL/min/1.73 m(2); and $1254; 99% CI, $134-$2373 for their combination). The study consistently found excess health care spending over the following 5 examined years.Conclusions and Relevance In this cohort study of nationwide health checkup and medical claims data in Japan, early-stage CKD was associated with excess health care spending over the 5 examined years, and the association was more pronounced with a more advanced disease stage.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The Impact of Early-Stage Chronic Kidney Disease on Weight Loss Outcomes After Gastric Bypass
    João Pereira
    Pedro R. Pereira
    Sara Andrade
    Sofia S. Pereira
    Mário Nora
    Marta Guimarães
    Mariana P. Monteiro
    Obesity Surgery, 2023, 33 : 3767 - 3777
  • [32] Early-stage chronic kidney disease as a risk factor for suicide: a nationwide observational cohort study
    Joo, Kwon Wook
    Park, Sehoon
    Kim, Jung-Hyun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2272 - I2273
  • [33] General practitioners' perspectives on management of early-stage chronic kidney disease: a focus group study
    van Dipten, Carola
    van Berkel, Saskia
    de Grauw, Wim J. C.
    Scherpbier-de Haan, Nynke D.
    Brongers, Bouke
    van Spaendonck, Karel
    Wetzels, Jack F. M.
    Assendelft, Willem J. J.
    Dees, Marianne K.
    BMC FAMILY PRACTICE, 2018, 19
  • [34] Early-stage chronic kidney disease as a risk factor for suicide: a nationwide observational cohort study
    Joo, Kwon Wook
    Park, Sehoon
    Kim, Jung-Hyun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [35] General practitioners’ perspectives on management of early-stage chronic kidney disease: a focus group study
    Carola van Dipten
    Saskia van Berkel
    Wim J. C. de Grauw
    Nynke D. Scherpbier-de Haan
    Bouke Brongers
    Karel van Spaendonck
    Jack F. M. Wetzels
    Willem J. J. Assendelft
    Marianne K. Dees
    BMC Family Practice, 19
  • [36] Pharmaceutical spending and early-stage innovation in EU countries
    Kourouklis, Dimitrios
    Gandjour, Afschin
    INDUSTRY AND INNOVATION, 2022, 29 (10) : 1141 - 1170
  • [37] Hypertension in Early-Stage Kidney Disease: An Update From the Kidney Early Evaluation Program (KEEP)
    Kalaitzidis, Rigas
    Li, Suying
    Wang, Changchun
    Chen, Shu-Cheng
    McCullough, Peter A.
    Bakris, George L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : S22 - S31
  • [38] Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort
    Dufour, Aurelie
    Kurtz, Kelly-Anne
    Vachey, Clement
    Mac-Way, Fabrice
    CLINICAL KIDNEY JOURNAL, 2025, 18 (02)
  • [39] Association between early-stage chronic kidney disease and reduced choroidal thickness in essential hypertensive patients
    Giuseppe Mulè
    Maria Vadalà
    Tiziana La Blasca
    Rossella Gaetani
    Giuseppe Virone
    Marco Guarneri
    Massimo Castellucci
    Giulia Guarrasi
    Micol Terrasi
    Santina Cottone
    Hypertension Research, 2019, 42 : 990 - 1000
  • [40] Risk for cognitive impairment across 22 measures of cognitive ability in early-stage chronic kidney disease
    Torres, Rachael V.
    Elias, Merrill F.
    Seliger, Stephen
    Davey, Adam
    Robbins, Michael A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (02) : 299 - 306